Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
Titel:
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
Auteur:
Soria, Jean-Charles Wu, Yi-Long Nakagawa, Kazuhiko Kim, Sang-We Yang, Jin-Ji Ahn, Myung-Ju Wang, Jie Yang, James Chih-Hsin Lu, You Atagi, Shinji Ponce, Santiago Lee, Dae Ho Liu, Yunpeng Yoh, Kiyotaka Zhou, Jian-Ying Shi, Xiaojin Webster, Alan Jiang, Haiyi Mok, Tony S K